City snapshot: FeverTree annual sales rise 10% but coronavirus impact will be ‘material’

Fever-Tree

FeverTree annual revenues surged but the company expects “material impact” from the coronavirus pandemic. Plus, Glanbia’s 2020 sales rise but it withdraws full year guidance and all the rest of the latest news from the City.

 

Already have an account? Sign in here

You’ve used up your article allowance

Sign up to read more stories for free

Register now